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In the second paragraph of the Introduction section, the last portion of the first sentence states: "... and approved for use for the treatment of osteoporosis in Japan \[11\]." This was inadequately referenced, and should be "approved for use for the treatment of osteoporosis in Japan \[11, 17--19\]."

In the fourth paragraph of the Discussion section, the first portion of the first sentence states: "While many reports have indicated the bone density-increasing effects of switching to daily minodronate from other BPs \[11, 17--19\], ..." This was incorrectly referenced, and should be "While many reports have indicated the bone density-increasing effects of switching to daily minodronate from other BPs \[23--25\], ..."

In the fifth paragraph of the Discussion section, the first portion of the first sentence states: "While daily minodronate has been reported to alleviate low back pain \[19\], ...". Additionally, in the sixth paragraph of the Discussion section, the first sentence states: "We have already reported that daily minodronate treatment induced fewer GI symptoms in comparison with weekly alendronate treatment \[19\]." The reference number \[19\] is incorrect and should be \[18\] in both cases.

An inappropriate publication was cited as reference 21. The correct reference is:

21\. Nozaki K, Kakimoto S, Kimoto A, Yoshino T, Sato Y, Yoshida A, Nakamura T (2011) Investigation into the analgesic effects of minodronic acid hydrate via P2X~2/3~ receptor (in Japanese). Shinyaku To Rinsho (J New Rem Clin) 60(9):1766--1774

The following three publications should have been included in the References section.

23\. Shimoda J (2010) Clinical experience with minodronate for the treatment of osteoporosis unresponsive to alendronate therapy (in Japanese). Osteoporosis Jpn 18(4):739--744

24\. Kogawa R, Takagi H (2011) Clinical efficacy of minodronic acid hydrate, a newly developed bisphosphonate, in osteoporotic patients who responded poorly to alendronate therapy (in Japanese). Osteoporosis Jpn 19(4):725--734

25\. Matsui H (2012) Clinical effects of minodronic acid hydrate in patients with postmenopausal osteoporosis who underwent first bisphosphonate therapy or pretreatment with risedronate (in Japanese). Central Japan Association of Orthopaedic Surgery & Traumatology 55(3):531--532

The online version of the original article can be found at 10.1007/s00198-014-2756-8.
